Azacitidine Maintenance Versus No Maintenance after Standard Therapy in Patientswith Acute Myeloid Leukemia, a Mexican Center Experience

被引：0
|
作者：
De La Pena, Antonio
Fermin-Caminero, Denisse J.
Teomitzi-Sanchez, Oscar
Arana, Luara
Alvarez, Jose
Perez, Juan Manuel
Espitia, Maria Eugenia
Hernandez, Eleazar
Alvarado, Martha
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-142855
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Real World Outcomes of Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia: A Single Center Experience
    Zahra, Fatima Tuz
    Ong, Faustine
    Walgenbach, Daniel
    Chan, Onyee
    Tobon, Katherine
    Lancet, Jeffrey E.
    Sallman, David
    Komrokji, Rami S.
    Kuykendall, Andrew T.
    Padron, Eric
    Walker, Alison R.
    Xie, Zhuoer
    Yun, Seongseok
    BLOOD, 2024, 144 : 2415 - 2416
  • [2] Oral Azacitidine Maintenance for Acute Myeloid Leukemia
    Perissinotti, Anthony J.
    Benitez, Lydia L.
    Marini, Bernard L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13):
  • [3] Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
    Wei, A. H.
    Dohner, H.
    Pocock, C.
    Montesinos, P.
    Afanasyev, B.
    Dombret, H.
    Ravandi, F.
    Sayar, H.
    Jang, J. -H.
    Porkka, K.
    Selleslag, D.
    Sandhu, I.
    Turgut, M.
    Giai, V.
    Ofran, Y.
    Cakar, M. Kizil
    de Sousa, A. Botelho
    Rybka, J.
    Frairia, C.
    Borin, L.
    Beltrami, G.
    Cermak, J.
    Ossenkoppele, G. J.
    La Torre, I.
    Skikne, B.
    Kumar, K.
    Dong, Q.
    Beach, C. L.
    Roboz, G. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (26): : 2526 - 2537
  • [4] Indirect treatment comparison of oral versus injectable azacitidine as maintenance therapy for acute myeloid leukemia
    Tabah, Ashley
    Huggar, David
    Wang, Si-Tien
    Johnson, Scott J.
    Copher, Ronda M.
    O'Connell, Thomas
    McBride, Ali
    LeBlanc, Thomas W.
    FUTURE ONCOLOGY, 2022, 18 (37) : 4089 - 4099
  • [5] Oral Azacitidine Maintenance Therapy in Acute Myeloid Leukemia after Frontline Hypomethylating Agent and Venetoclax
    Canavan, Cody
    Knight, Thomas G.
    Shah, Nilay A.
    Chojecki, Aleksander L.
    Ai, Jing
    Levine, Jonathan K.
    Osei-Boateng, Kwabena
    Hiremath, Adarsh
    Grunwald, Michael R.
    BLOOD, 2024, 144 : 6036 - 6037
  • [6] Oral Azacitidine Maintenance for Acute Myeloid Leukemia Reply
    Wei, Andrew H.
    Doehner, Hartmut
    Roboz, Gail J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13):
  • [7] Maintenance therapy with a combination of azacitidine, danazol, and thalidomide after intensive chemotherapy in patients with acute myeloid leukemia
    Zheng, Fang
    Li, Qianqian
    Yang, Sisi
    Zhou, Zhen
    Zeng, Qingfan
    Liu, Kaiqi
    HEMATOLOGY, 2023, 28 (01)
  • [8] Maintenance Therapy with Combination of Azacitidine, Danazol and Thalidomide after Intensive Chemotherapy in Acute Myeloid Leukemia Patients
    Zheng, Fang
    Li, Qianqian
    Yang, Sisi
    Zhou, Zhen
    Zeng, Qingfan
    Mi, Yingchang
    Liu, Kaiqi
    BLOOD, 2022, 140 : 11720 - 11722
  • [9] Maintenance Therapy in Acute Myeloid Leukemia
    Sabakhtarishvili, Giorgi
    Ansari, Amir
    Tabbara, Imad A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2025, 48 (01): : 38 - 43
  • [10] AZACITIDINE IN ACUTE MYELOID LEUKEMIA: A SINGLE CENTER EXPERIENCE
    Guaragna, G.
    Rinaldi, E.
    Girasoli, M.
    Spina, A.
    Quarta, G.
    Melpignano, A.
    HAEMATOLOGICA, 2015, 100 : 84 - 84
12345